Stocks gain as Bostic backs quarter-point hike; Hewlett Packard Enterprise lifts annual guidance after Q1 results beat estimates; Fed wrestles whether recent data a 'blip' or a warning on inflation Whether its bringing more than a dozen key medicines to market since 2009, or expanding patient access to medicine, our commitment to patients inspires us and guides our actions as responsible corporate citizens. Our work is challenging and you shouldn't have to go it alone. (. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram. , M@C(c{H?X8 G ,Lv9 A00Lbd`d: p` The companys performance in the first quarter of 2021 Furthermore, one of the three required milestones for payment of the Bristol Myers Squibb Contingent Value Right (CVR) remained unaccomplished due to the pending FDA approval as of Dec. 31, 2020. Job security always hanging over your head. Up to 100% of qualifying tuition costs may be covered, based upon manager discretion and budget. "Simply because we are attracting the best talent to better serve patients now, while at the same time we're focusing on developing strategic partnerships to grow our pipeline of next generation assets and deliver on our commitment to the patients of tomorrow." Senior Research Investigator salaries ($93k), Research Investigator II salaries ($108k), Associate Research Scientist I salaries ($70k), Senior Research Investigator II salaries ($132k), Associate Research Scientist II salaries ($77k). "Bristol Myers Squibb is well positioned to build on our success in 2021 and continue to grow our company through the end of the decade." Giovanni Caforio hA 04Fq\GczC. Gordon Dyal & Co., LLC is serving as the exclusive financial advisor to Bristol Myers Squibb, and Kirkland & Ellis LLP is serving as legal counsel. ET. July 28 (Reuters) - Bristol Myers Squibb Co (BMY.N) reported second quarter earnings that topped Wall Street estimates, as sales of flagship cancer treatment Opdivo returned to growth after. paid time off and holidays- employees are expected to work holidays at times. Warnings Bristol-Myers Squibb Co and Eisai Co said on Thursday they had entered into an agreement worth up to $3.10 billion to jointly develop and market an experimental cancer drug. Learn about our safety approach to COVID-19 > At Bristol Myers Squibb, the work you do-often in support of emerging therapeutic areas that require new methods of thinking and working-will help people prevail over serious diseases. This led to the automatic termination of the CVR agreement Jan. 1,2021 rendering the CVRs as ineligible for payment under the agreement. Bristol-Myers June 17 (Reuters) - Bristol-Myers Squibb Co BMY.N and Eisai Co said on Thursday they had entered into an A Reminder to Patients Applying to the Bristol Myers Squibb Patient Assistance Foundation (BMSPAF) If you are applying to BMSPAF for the first time or for continued assistance, your application may be processed more quickly if you include proof of your household income from a Federal Tax Return or other sources of income documentation including: [Updated: 3/26/2021] BMY Stock Looks Undervalued At $63. Our expansive library of resources covers a wide range of special interest topics in multiple languages through a variety of top learning and development resources powered by LinkedIn Learning. Home; Our Services; About us; Blog; Contact Major Holidays. Bristol-Myers Squibb Co (BMS) is a specialty biopharmaceutical company that is engaged in discovery, development, licensing and manufacturing, marketing, distribution and sale of medicines and related medical products to patients with serious diseases. The sale was disclosed in a legal filing Bristol Myers Squibb announced on Feb. 5 that the US Food and Drug Administration (FDA) has approved its lymphoma drug, Breyanzi, a CAR-T (chimeric antigen receptor T-cell) therapy for the treatment of adult patients suffering from relapsed or refractory large B-cell lymphoma. 0000006923 00000 n And while our work transforms the lives of patients, it also transforms the lives and careers of those who do it. There are no upcoming events. Learn more! With your consent, we may also use third party cookies to analyze your usage of the website. The stock was sold at an average price of $64.21, for a total transaction of $200,270.99. There are regular US holidays with 4 floating holiday/personal days. We are honored to be recognized by Fortune once again as one of the Worlds Most Admired Companies. Connect with a more experienced colleague to be your sounding board and to help guide you forward. I n the latest trading session, Bristol Myers Squibb (BMY) closed at $67.34, marking a -0.07% move from the previous day. Apr 27, 2021 (The Expresswire) -- Covid -19 Impact to global Stroke Treatment Drugs Market for 2015-2025. Investors. 0000192949 00000 n This earnings release and the accompanying tables also provide certain revenues and expenses as well as non-GAAP measures excluding the impact of foreign exchange. Shareholder proposals relating to our 2021 Annual Meeting of Shareholders must be received by us at our principal executive offices, Bristol-Myers Squibb Company, 430 East 29th Street14th Floor, New York, New York 10016, Attention: Corporate Secretary, no later than November 25, 2020. The variability of the specified items may have a significant and unpredictable impact on our future GAAP results. Image Source: Zacks Investment Research. Here we feature several BMS colleagues sharing their views on the subject from their perspectives, based on their own experiences. The financial guidance is subject to risks and uncertainties applicable to all forward-looking statements as described elsewhere in this press release. Our financial strength, dedicated workforce and proven ability to execute will enable us to continue to advance our pipeline, invest in future sources of innovation and position the company for sustained growth., $ amounts in millions, except per share amounts. The company was founded in 1887 and is based in New York, New York. Investor Relations: investor.relations@bms.com They encouraged employees to take their vacations. Non-GAAP financial measures such as non-GAAP earnings and related EPS information are adjusted to exclude certain costs, expenses, gains and losses and other specified items that are evaluated on an individual basis after considering their quantitative and qualitative aspects and typically have one or more of the following characteristics, such as being highly variable, difficult to project, unusual in nature, significant to the results of a particular period or not indicative of past or future operating results. Rosh Chodesh. Gross margin increased from 73.7% to 80.3% in the quarter primarily due to an impairment charge related to marketed product rights in the same period a year ago and lower unwinding of inventory purchase price accounting adjustments. Learn about joining our global team! Investor Relations: investor.relations@bms.com, Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021, https://www.businesswire.com/news/home/20220204005037/en/, Bristol Myers Squibb posted fourth quarter revenues of $12.0 billion, an increase of 8%, driven by. System. Bristol Myers Squibb Paid Holidays 106 employees reported this benefit 4.3 20 Ratings Available to US-based employees Change location Employee Comments Showing 1-10 of 20 Jan 28, 2023 4.0 Current Direcror in nullnull Comparable to many others in the same league Helpful Report Dec 22, 2022 4.0 "The first of the new aircraft will enter service in late-2023, with the bulk to . Our mission to enhance the lives of patients requires an investment in a strong learning culture. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item. Bristol-Myers would pay $650 million, including for research and development expenses to Eisai, which will also be eligible for up to $2.45 billion in milestone payments, the companies said.. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram. There is a pregnancy exposure registry that monitors the outcomes of females who take REVLIMID during pregnancy, or if their male partner takes REVLIMID and they are exposed during pregnancy. %PDF-1.5 % In addition, the financial guidance provided in this release relies on assumptions about the duration and severity of the COVID-19 pandemic, timing of the return to a more stable business environment, patient and physician behaviors, buying patterns and clinical trial activities, which may prove to be incorrect. Turning Point Therapeutics Board of Directors unanimously recommends that Turning Point Therapeutics shareholders tender their shares in the tender offer. The case is UMB Bank NA v Bristol-Myers Squibb (NYSE: BMY) Co et al, U.S. District Court, Southern District of New York, No. ** Included as part of the new product portfolio Add to iCalendar. I am ready to take up a new challenge and I would like to take this opportunity to put the knowledge and skills acquired during my career at the service of my new employer and future colleagues. These statements may be identified by the fact they use words such as should, could, expect, anticipate, estimate, target, may, project, guidance, intend, plan, believe, will and other words and terms of similar meaning and expression in connection with any discussion of future operating or financial performance, although not all forward-looking statements contain such terms. 0000042788 00000 n With repotrectinib, we have the opportunity to change the standard of care and address a significant unmet medical need for ROS1-positive non-small cell lung cancer patients., Through this transaction, we will be able to harness the full potential of our precision oncology platform to advance the standard of care for cancer patients. Glassdoor is your resource for information about the Paid Holidays benefits at Bristol Myers Squibb. Reconciliations of the non-GAAP financial measures to the most comparable GAAP measures are provided in the accompanying financial tables and also available on the companys website at www.bms.com. Learn about 2023 benefits. Usually give off For the year end holidays too! UA 0000005488 00000 n The company continues to maintain a consistent, balanced approach to capital allocation focused on prioritizing investment for growth through business development along with reducing debt, commitment to dividend growth and share repurchase. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.You can see all of today's research reports here >>>Bristol-Myers Squibb's shares . Bristol-Myers Squibb had a positive return on equity of 33.76% and a negative net margin of 14.53%. We have the responsibility to protect and respect personal information. Manage cover for holidays and absenteeism for warehouse staff through Time Management. The Office of Corporate Conduct is a resource for any employee to confidentially and anonymously report their concerns or raise questions. Bristol Myers Squibb Paid Holidays 106 employees reported this benefit 4.3 20 Ratings Available to US-based employees Change location Employee Comments Showing 1-10 of 20 28 Jan 2023 4.0 Current Direcror in nullnull Comparable to many others in the same league Helpful Report 22 Dec 2022 4.0 The company reported net earnings attributable to Bristol Myers Squibb of $2.4 billion, or $1.07 per share, in the fourth quarter, compared to net loss of $10.0 billion, or $(4.45) per share, for the same period a year ago. A method of treating a disorder mediated by BRD9 comprising administering an effective amount of a compound of Formula: or a pharmaceutically acceptable salt thereof Source: Bristol-Myers Squibb The transaction is the biggest acquisition ever announced so early in a calendar year, according to data compiled by Bloomberg going back to 1990. Bristol-Myers Squibb bulls will hope to hear the company announce they've not only beaten. If, like us, you believe in the power of science to address some of the most challenging diseases of our time, then youll fit right in as we search for the next breakthroughs in biopharma. Learn about Bristol Myers Squibb Vacation & Paid Time Off, including a description from the employer, and comments and ratings provided anonymously by current and former Bristol Myers Squibb employees. All statements that are not statements of historical facts are, or may be deemed to be, forward-looking statements. 07/29/21 : Interim 2021 Earnings Release (Projected) 10/28/21 : Q3 2021 Earnings Release (Projected) 01/27/22 : FY 2021 Earnings Release (Projected) 04/28/22 Bristol-Myers would pay $650 million, including for research and development expenses to Eisai, which will also be eligible for up to $2.45 billion in milestone payments, the companies said. 2021 was a pivotal year for our company as we achieved significant regulatory and clinical milestones and positioned the company to successfully renew our portfolio. Worldwide revenues are expected to be approximately $47 billion, representing an increase in the low-single digits. Bristol-Myers Squibb's report follows an earnings beat by J&J on January 26, who reported EPS of $1.86 on revenue of $22.48B, compared TipRanks Team May 19, 2021. Actual results may differ materially from current expectations because of numerous risks and uncertainties including with respect to (i) the timing of the tender offer and the subsequent merger, (ii) the number of shares of the Turning Point Therapeutics common stock that will be tendered in the tender offer, (iii) the risk that the expected benefits or synergies of the acquisition will not be realized, (iv) the risk that legal proceedings may be instituted related to the merger agreement, (v) any competing offers or acquisition proposals for Turning Point Therapeutics, (vi) the possibility that various conditions to the consummation of the tender offer or the acquisition may not be satisfied or waived, including that a governmental entity may prohibit, delay or refuse to grant approval for the consummation of the offer or the acquisition and (vii) unanticipated difficulties or expenditures relating to the proposed transaction, the response of business partners and competitors to the announcement of the proposed transaction and/or potential difficulties in employee retention as a result of the announcement and pendency of the proposed transaction. Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. Repotrectinib, which is being studied in a registrational Phase 2 study in adults and a Phase 1/2 study in pediatric patients, has shown antitumor activity and durable responses among kinase inhibitor treatment-nave and pre-treated patients. Play. No additional data or studies have been requested. Learn more! (( g The effective tax benefit rate was 27.7% in the quarter. The forward-looking statements made in this communication relate only to events as of the date on which the statements are made. These items are excluded from non-GAAP earnings and related EPS information because Bristol Myers Squibb believes they neither relate to the ordinary course of Bristol Myers Squibbs business nor reflect Bristol Myers Squibbs underlying business performance. Bristol-Myers Squibb Company (BMY) NYSE - Nasdaq Real Time Price. Non-GAAP EPS . Choosing Your Medical Plan. Access thousands of interactive online resources to gain the skills you need, when you need them. Month List Download. Bristol Myers Squibb is well positioned to build on our success in 2021 and continue to grow our company through the end of the decade. Media: media@bms.com Available to US-based employeesChange location, Comparable to many others in the same league. (Reuters) - A judge in Hawaii on Monday ordered Bristol-Myers Squibb (NYSE: BMY) Co and Sanofi (NASDAQ: SNY) SA Following the sale, the senior vice president now directly owns 16,243 shares in the company, valued at $1,042,963.03. Minor Holidays . Insights for Success: We are committed to creating an inclusive environment and have invested in training for woman and underrepresented groups. Bristol-Myers Squibb is a multinational pharmaceutical company headquartered in New York City. Our Insights for Success program is offered to diverse employees to enhance their organizational and personal career success and ensure equitable leadership throughout the company. Bristol Myers Squibb (NYSE:BMY) today reports results for the fourth quarter and full year of 2021, which reflect strong sales driven by robust commercial execution and significant advancement of the companys pipeline that further progressed the companys portfolio renewal. If you have $1,000 at the ready, pharmaceutical stock Bristol Myers Squibb *Stock Advisor returns as of June 7, 2021. Is Bristol Myers Squibb (BMY) Stock Outpacing Its Medical Peers This Year? Mar 02, 2023 (Prime PR Wire via Comtex) -- This "Organ Transplant Rejection Medication Market" study analyses the market and offers thorough insights to help. 0000014201 00000 n Returns Potential A 15% price target upside from sell-side analysts. ,,M|L7^`kBQv# |88960\epmPZyC?r= ,L*P}``rN Kitchenettes with vending machines, free coffee and tea. The non-GAAP financial measures are provided as supplemental information to the financial measures presented in this communication that are calculated and presented in accordance with GAAP and are presented because management has evaluated the companys financial results both including and excluding the adjusted items or the effects of foreign currency translation, as applicable, and believes that the non-GAAP financial measures presented portray the results of the company's baseline performance, supplement or enhance management, analysts and investors overall understanding of the companys underlying financial performance and trends and facilitate comparisons among current, past and future periods. Print. Bristol-Myers Squibb BMY | stock $69.02 0.09% $147 B 3.31% $2.28 - Ratings - BMY Dividend Safety A+ 16 years of consecutive dividend increase. "Simply because we are attracting the best talent to better serve patients now, while at the same time we're focusing on developing strategic partnerships to grow our pipeline of next generation assets and deliver on our commitment to the patients of tomorrow.". Bristol-Myers Squibb (NYSE: BMY) is a global biopharmaceutical company committed to discovering, developing, and delivering medicines that help patients prevail over serious diseases. )yJP These statements are likely to relate to, among other things, the companys ability to execute successfully its strategic plans, including its business development strategy and capital allocation strategy, planned product launches and updates, expectations relating to its pipeline and in relation to its ability to realize the projected benefits of the Celgene acquisition and the MyoKardia acquisition, the full extent of the impact of the COVID-19 pandemic on the companys operations and the development and commercialization of its products, potential laws and regulations to lower drug costs, market actions taken by private and government payers to manage drug utilization and contain costs, the expiration of patents or data protection on certain products, including assumptions about the companys ability to retain patent exclusivity of certain products, and the impact and the result of governmental investigations. We are proud of our companys global commitment to Inclusion & Diversity and the meaningful steps we are taking to drive equitable advancement and outcomes for all. And while our work transforms the lives of patients, it also transforms the lives and careers of those who do it. Your future colleagues at Bristol Myers Squibb are impacting lives every day. Jun 11, 2021 5:45PM EDT. Deferred and current income taxes attributed to these items are also adjusted for considering their individual impact to the overall tax expense, deductibility and jurisdictional tax rates. Bristol Myers Squibb posted third quarter revenues of $11.2 billion, a decrease of 3%, driven by recent LOE products (primarily Revlimid) and foreign exchange impacts, partially offset by in-line products (primarily Eliquis and Opdivo) and our new product portfolio . Gregorian year (common era) Hebrew year. Our people Our global workforce is made up of over 26,000 passionate people who, in 2021, helped Pandora record the highest earnings to date, led by a refreshed long-term growth strategy. In the Phase 1/2 TRIDENT-1 clinical trial, longer duration of response has been observed in the landmark analysis with repotrectinib than with existing ROS1 agents in first-line NSCLC. bristol myers squibb Dublin, Ireland . Show more Show less Resident Advisor Bucknell University . Bristol-Myers in May entered into a $1.56 billion deal with Agenus Inc to exclusively develop and market its experimental drug for immuno-oncology treatments, including non-small-cell lung cancer. 0000003993 00000 n We know its not easy to make a difference, so we make sure each employee feels empowered and motivated in their efforts to do so. Bristol Myers Squibb is introducing its 2022 GAAP EPS guidance range of $3.37 - $3.67 and reaffirming its non-GAAP EPS guidance range of $7.65 - $7.95. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our estimates change, whether as a result of new information, future events or otherwise. Bristol Myers Squibb (NYSE:BMY) will announce results for the first quarter of 2021 on Thursday, April 29, 2021. Income tax benefit was approximately $510 million despite pre-tax earnings of $1.9 billion in the quarter primarily due to the impact of internal transfers of certain intangible assets of $1.0 billion. Bristol-Myers Squibb Company (BMY) will begin trading ex-dividend on September 30, 2021. During a conference call at 9 a.m. Shares of Bristol Myers Squibb Co. BMY, +0.36% shed 2.1% in premarket trading Thursday, after the drug maker reported a first-quarter profit that BMY AGEN. No matter the role within BMS, we all embrace a patient-centric culture. Selling, General & Admin. In addition, a copy of the offer to purchase, letter of transmittal and certain other related tender offer documents (once they become available) may be obtained free of charge at www.bms.com or by directing a request to Bristol Myers Squibb, Office of the Corporate Secretary, 430 East 29th Street, 14th Floor, New York, New York 10154-0037. . General and technical inquiries. (, In December, the company announced that its Board of Directors approved an increase in the quarterly dividend and authorized an additional $15 billion, multi-year share repurchase program. People and Business Resource Groups are provided mentor/mentee learning and development among employees on a global scale. This was driven by its aforementioned revenue growth, a 330-basis-point. For your convenience, specialized Bristol Myers Squibb representatives are available by phone or email to help you with your medical, technical, or general inquiries. The recognition is a testament to our commitment to transform patients lives through science. 0000007092 00000 n We believe in a Total Rewards experience that enriches your life today and engages and empowers you to save, perform, grow, and build toward all of your tomorrows. 0000043468 00000 n endobj 0000005253 00000 n Cautionary Statement Regarding Forward-Looking Statements. Copyright 20082023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Former Sales Training Manager in nullnull, Current Maintenance Engineer in Manati, PR, Puerto Rico, Current Senior Manufacturing Engineer in New Brunswick, NJ, New Jersey, Former Senior Financial Analyst in Princeton, NJ, New Jersey. This communication contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, the acquisition of Turning Point Therapeutics by the company and the development and commercialization of certain biological compounds. Available to US-based employeesChange location, Comparable to many others in the same league. Find out why possibility lives at Bristol Myers Squibb, We demonstrate ethics, integrity and quality in everything we do for patients, customers and colleagues, We pursue disruptive and bold solutions for patients, We move together with speed and quality because patients are waiting, Our dedication to learning and excellence helps us to deliver exceptional results, We all own BMS success and strive to be transparent and deliver on our commitments, We embrace diversity and foster an environment where we can all work together at our full potential. 0000002778 00000 n I am confident in our ability to execute against our key milestones in 2022, including three planned first-in-class launches with relatlimab plus nivolumab fixed dose combination, mavacamten and deucravacitinib. All comparisons are made versus the same period in 2020 unless otherwise stated. Every year, key managers and executives are required to certify that they have read, understand, are in compliance with, and will continue to comply with our Standards of Business Conduct and Ethics. 0000009995 00000 n Total Rewards may differ based on country; the benefits described on this site are specific to those in the U.S. We do this in a few ways: We are a culture of savers who recognize the value of saving early and often and seize the opportunities to do so. The extension will allow sufficient time to review information pertaining to updates of the proposed Risk Evaluation Mitigation Strategy (REMS). No cons. <>stream 867 0 obj It includes chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. When you join one of our diverse, high-achieving teams, youll collaborate each day to help transform the lives of patients around the world. And while our work transforms the lives of patients, it also transforms the lives and careers of those who do it. The basis for our security efforts is to protect our employees, operations and intellectual property. Neither the company nor Turning Point Therapeutics undertakes any obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. The recognition is a testament to our commitment to transform patients lives through science. Share; Facebook; Twitter; LinkedIn . Tuesday, November 16, 2021. Learn about joining our global team! In addition, the company believes such a reconciliation would imply a degree of precision and certainty that could be confusing to investors. 0000004898 00000 n Research and development expenses decreased 30% to $2.6 billion in the quarter. Elizabeth Mily joined Bristol Myers Squibb Co. as executive vice president of strategy and business development in March 2020 after 27 years in investment banking. Whether recruiting from academia or the commercial biopharma sector, Mihaela explains why a move to BMS is a great career move. 3 floating holidays. Bristol Myers Squibb to Participate in the 39th Annual J.P. Morgan Healthcare Conference testtest test. Shareholders who. 0000008533 00000 n More information on suppliers is available here. It offers chemically-synthesized drugs or. They offer 3 weeks after 3 or 4 years and they go up every couple of years. Tuition reimbursement is available to eligible employees who, through their own initiation and desire for development, participate in accredited educational programs that their manager deems will be mutually beneficial to BMS and the employee. Upcoming events. Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Opdivo (nivolumab) plus Yervoy (ipilimumab) for Treatment of Mismatch Repair Deficient or Microsatellite InstabilityHigh Metastatic Colorectal Cancer After Prior Chemotherapy. Catalyst and Talent Accelerator: unique programs designed to accelerate the leadership potential of high performing individuals to drive global innovation and business results. Required to work every rotating weekends, some holidays, and during adverse weather conditions in support of . This website uses cookies to provide website functionality. Reconciliations of these non-GAAP financial measures to the most comparable GAAP measures for a particular quarterly period are available on the companys website at www.bms.com., Risk Evaluation and Mitigation Strategies (REMS), Pre-Approval Access to Investigational Medicines, Areas of Interest & Competitive Research Grants, The Thomas O. Daniel Research Incubator and Collaboration Center, Acquisition FAQs for Celgene Shareholders, Acquisition-related information for Celgene shareholders, Unsubscribe to News Email Alerts - Bristol Myers Squibb, Subscribe to New Email Alerts - Bristol Myers Squibb, BMS at June 2022 oncology and hematology congresses, Committed to creating a better future for cancer patients, People & Business Resource Groups leadership team, Our Commitment to Equal Employment Opportunity, Access to Medicines in the Developing World, UK-CA Slavery and Human Trafficking Statement (PDF), Our Commitment to Global Inclusion & Diversity>. View this presentation. Currency in USD Follow 2W 10W 9M 70.18 -1.22 (-1.71%) At close: 04:00PM EST 70.40 +0.22 (+0.31%) After hours: 07:43PM EST Time. Similar charges or gains were recognized in prior periods and will likely reoccur in future periods, including amortization of acquired intangible assets, including product rights that generate a significant portion of our ongoing revenue and will recur until the intangible assets are fully amortized, unwind of inventory purchase price adjustments, acquisition and integration expenses, restructuring costs, accelerated depreciation and impairment of property, plant and equipment and intangible assets, R&D charges or other income resulting from up-front or contingent milestone payments in connection with the acquisition or licensing of third-party intellectual property rights, divestiture gains or losses, stock compensation resulting from accelerated vesting of Celgene awards, certain retention-related employee compensation charges related to the Celgene transaction, pension, legal and other contractual settlement charges, equity investment and contingent value rights fair value adjustments (including fair value adjustments attributed to limited partnership equity method investments beginning in 2021) and amortization of fair value adjustments of debt acquired from Celgene in our 2019 exchange offer, among other items.
Field Artillery Units In Vietnam,
Section 10177 Of The Business And Professions Code,
Brooklands Primary School Staff,
Articles B